NCT05964322

Brief Summary

Children and adolescents with inherited cardiac arrhythmia su ch Long QT Syndrome (LQTS) have lower physical and quality of life than their healthy peers. A multi-component cardiac rehabilitation, including an exercise training program and education program, might counteract those effects. The goal of this pilot study is to evaluate the security, feasibility, and benefits of a cardiac rehabilitation program in children with LQTS aged between 6 to 18 years old. The main question\[s\] it aims to answer are:

  • Is center-based cardiac rehabilitation safe and feasible for children with LQTS?
  • Does a 12-week cardiac rehabilitation program improve physical fitness and quality of life?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2022

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 2, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 7, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 4, 2023

Completed
23 days until next milestone

First Posted

Study publicly available on registry

July 27, 2023

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

July 31, 2025

Status Verified

July 1, 2025

Enrollment Period

1.1 years

First QC Date

July 4, 2023

Last Update Submit

July 28, 2025

Conditions

Keywords

Cardiac RehabilitationLong QT syndromePediatricExercise trainingEducational program

Outcome Measures

Primary Outcomes (4)

  • Security

    Count and specify any cardiac events on the ECG scope during each session. Reporting of related and non-related event during the past 7 days through short questionnaire each week.

    At week 12

  • Recruitment rates

    Number of participants who completed baseline assessment compared to the number who were eligible (expressed in %).

    At week 12

  • Retention rates

    Participants who participated in the 12-week intervention and completed the follow-up assessments at the end of the program (expressed in %).

    At week 12

  • Adherence

    Percentage exercise sessions attained by participants compared to number of sessions proposed.

    At week 12

Secondary Outcomes (8)

  • Change on cardiorespiratory fitness

    between week 0 and week 12

  • Change on muscle architecture

    between week 0 and week 12

  • Change on muscle strength

    between week 0 and week 12

  • Change on physical activity level

    between week 0 and week 12

  • Change on Self reported total score of the Pediatric Quality of Life Inventory (PedsQL) 4.0 questionnaire

    between week 0 and week 12

  • +3 more secondary outcomes

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children aged 8 to 18 years with an LQTS.

* Children and adolescents, aged 6 to 18 years old, diagnosed with congenital LQTS and had been recently under medical check-up in our last study QUALIMYORYTHM * With impaired cardiorespiratory fitness (VO2 peak \<80% of predicted values or VAT \<55% of predicted values) or with normal cardiorespiratory fitness but requiring patient education and information on limits/security in taking part in sports participation. * Willingness and ability for parents and children to take part in a 12-week center-based program (e.g., availability during the school period, transportation options) * Informed consent of parents or legal guardians, and oral assent of children.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (2)

University Hospital of Montpellier - Arnaud de Villeneuve Hospita

Montpellier, 34295, France

Location

Saint-Pierre Institute

Palavas-les-Flots, 34250, France

Location

Related Publications (3)

  • Souilla L, Avesani M, Boisson A, Requirand A, Matecki S, Vincenti M, Werner O, De La Villeon G, Pommier V, Pasquie JL, Guillaumont S, Amedro P. Cardiorespiratory fitness, muscle fitness, and physical activity in children with long QT syndrome: A prospective controlled study. Front Cardiovasc Med. 2023 Jan 11;9:1081106. doi: 10.3389/fcvm.2022.1081106. eCollection 2022.

    PMID: 36712265BACKGROUND
  • Amedro P, Werner O, Abassi H, Boisson A, Souilla L, Guillaumont S, Calderon J, Requirand A, Vincenti M, Pommier V, Matecki S, De La Villeon G, Lavastre K, Lacampagne A, Picot MC, Beyler C, Delclaux C, Dulac Y, Guitarte A, Charron P, Denjoy-Urbain I, Probst V, Baruteau AE, Chevalier P, Di Filippo S, Thambo JB, Bonnet D, Pasquie JL. Health-related quality of life and physical activity in children with inherited cardiac arrhythmia or inherited cardiomyopathy: the prospective multicentre controlled QUALIMYORYTHM study rationale, design and methods. Health Qual Life Outcomes. 2021 Jul 28;19(1):187. doi: 10.1186/s12955-021-01825-6.

    PMID: 34321045BACKGROUND
  • Souilla L, Guillaumont S, Auer A, Metzler G, Requirand A, Vincenti M, De La Villeon G, Pasquie JL, Mottet D, Amedro P. Cardiac rehabilitation in children and adolescents with long QT syndrome: the RYTHMO'FIT pilot study. BMC Sports Sci Med Rehabil. 2024 Jul 12;16(1):152. doi: 10.1186/s13102-024-00941-2.

MeSH Terms

Conditions

Long QT SyndromePrecursor Cell Lymphoblastic Leukemia-Lymphoma

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseaseHeart Defects, CongenitalCardiovascular AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPathologic ProcessesPathological Conditions, Signs and SymptomsLeukemia, LymphoidLeukemiaNeoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Officials

  • Pascal AMEDRO, Professor

    University Hospital of Bordeaux - Haut-Levêque Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2023

First Posted

July 27, 2023

Study Start

February 2, 2022

Primary Completion

March 7, 2023

Study Completion

December 31, 2024

Last Updated

July 31, 2025

Record last verified: 2025-07

Locations